Next Issue
Volume 11, October
Previous Issue
Volume 11, September
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
0.9
1.1
Journals
Hematology Reports
Volume 11
Issue 4
share announcement
Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.

Hematol. Rep., Volume 11, Issue 4 (November 2019) – 6 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
1 pages, 252 KiB  
Correction
Erratum: Managing Acute Promyelocytic Leukemia in Patients Belonging to the Jehovah’s Witness Congregation
by Anand P. Jillella, Martha L. Arellano, Leonard T. Heffner, Manila Gaddh, Amelia A. Langston, Hanna J. Khoury, Abhishek Mangaonkar and Vamsi K. Kota
Hematol. Rep. 2019, 11(4), 8395; https://doi.org/10.4081/hr.2019.8395 - 4 Dec 2019
Viewed by 321
Abstract
Due to an error [...] Full article
3 pages, 331 KiB  
Article
Splenomegaly Impacts Prognosis in Essential Thrombocythemia and Polycythemia Vera: A Single Center Study
by Vincenzo Accurso, Marco Santoro, Simona Raso, Angelo Davide Contrino, Paolo Casimiro, Florinda Di Piazza, Alessandro Perez, Antonio Russo and Sergio Siragusa
Hematol. Rep. 2019, 11(4), 8281; https://doi.org/10.4081/hr.2019.8281 - 4 Dec 2019
Cited by 19 | Viewed by 633
Abstract
Splenomegaly is one of the major clinical manifestations of primary myelofibrosis and is common also in other chronic Philadelphia-negative myeloproliferative neoplasms, causing symptoms and signs and affecting quality of life of patients diagnosed with these diseases. We aimed to study the impact that [...] Read more.
Splenomegaly is one of the major clinical manifestations of primary myelofibrosis and is common also in other chronic Philadelphia-negative myeloproliferative neoplasms, causing symptoms and signs and affecting quality of life of patients diagnosed with these diseases. We aimed to study the impact that such alteration has on thrombotic risk and on the survival of patients with essential thrombocythemia and patients with Polycythemia Vera (PV). We studied the relationship between splenomegaly (and its grade), thrombosis and survival in 238 patients with et and 165 patients with PV followed at our center between January 1997 and May 2019. Full article
4 pages, 728 KiB  
Case Report
Aneurysm-Related Disseminated Intravascular Coagulation Successfully Treated by Endovascular Repair
by Miguel Lemos Gomes, Alice Lopes, Ana Parente Freixo, Gonçalo Sobrinho, Ruy Fernandes and Luís Mendes Pedro
Hematol. Rep. 2019, 11(4), 8189; https://doi.org/10.4081/hr.2019.8189 - 4 Dec 2019
Cited by 1 | Viewed by 480
Abstract
Aortic abdominal aneurysm (AAA) is an uncommon etiology of disseminated intravascular coagulation (DIC). The authors report a case of an 81-year-old male patient who presented with hematuria, intraoral hemorrhage, melaenas and ecchymosis of the lower back and of the abdominal wall, after being [...] Read more.
Aortic abdominal aneurysm (AAA) is an uncommon etiology of disseminated intravascular coagulation (DIC). The authors report a case of an 81-year-old male patient who presented with hematuria, intraoral hemorrhage, melaenas and ecchymosis of the lower back and of the abdominal wall, after being medicated with etoricoxib for a back pain. During the study, an abdominal aortic aneurysm, which prolonged to the left common and internal iliac artery, was discovered. The diagnosis of AAA induced DIC was made. After endovascular aneurysm repair (EVAR), the patient’s hemorrhagic manifestations disappeared and the laboratory findings normalized. In conclusion, the state-of-the-art treatment of DIC is the elimination of the underlying disease; in this case, EVAR was proven to be effective in treating the aortic aneurysm and the AAA-related DIC. Full article
5 pages, 510 KiB  
Article
Different Types of Amyloid Concomitantly Present in the Same Patients
by Francesca Martini, Gabriele Buda, Vincenzo De Tata, Sara Galimberti, Enrico Orciuolo, Matilde Masini and Mario Petrini
Hematol. Rep. 2019, 11(4), 7996; https://doi.org/10.4081/hr.2019.7996 - 4 Dec 2019
Cited by 3 | Viewed by 603
Abstract
Different types of amyloid concomitantly present in the same patient is believed to be improbable. We reported four cases of patients with plasma cell disorders who were found to have biopsy proven concomitant different types of amyloid fibrils deposition. We characterized amyloid fibrils [...] Read more.
Different types of amyloid concomitantly present in the same patient is believed to be improbable. We reported four cases of patients with plasma cell disorders who were found to have biopsy proven concomitant different types of amyloid fibrils deposition. We characterized amyloid fibrils using immunogold electron microscopy. There is lack of experience in the treatment of these frail and elderly patients, who are on the threshold between necessity of chemotherapy for AL amyloidosis and necessity to avoid harmful treatment related toxicity. All patients with a systemic amyloid syndrome require therapy to prevent deposition of amyloid in other organs and prevent progressive organ failure. Stem cell transplant (SCT) is preferred, but only 20% of patients are eligible Requirements for safe SCT include systolic blood pressure > 90 mm Hg, troponin T < 0.06 ng/mL, age < 70 years, and serum creatinine ≤ 1.7 mg/dL Nontransplant candidates can be offered melphalandexamethasone or cyclophosphamide-bortezomibdexamethasone. Full article
5 pages, 374 KiB  
Article
Clinicopathological Study and Outcomes of Primary Extranodal Lymphoma
by Nichapa Nanthakwang, Ekarat Rattarittamrong, Thanawat Rattanathammethee, Chatree Chai-Adisaksopha, Adisak Tantiworawit, Lalita Norasetthada and Charin Ya-In
Hematol. Rep. 2019, 11(4), 8227; https://doi.org/10.4081/hr.2019.8227 - 29 Nov 2019
Cited by 5 | Viewed by 513
Abstract
Lymphoma can present with either lymphadenopathy or extranodal involvement. There are limited clinicopathological data pertaining to the occurrence of primary extranodal lymphoma (pENL) in Thailand. This was a retrospective study conducted at Chiang-Mai University Hospital from 2012 to 2016. Patients 18 years of [...] Read more.
Lymphoma can present with either lymphadenopathy or extranodal involvement. There are limited clinicopathological data pertaining to the occurrence of primary extranodal lymphoma (pENL) in Thailand. This was a retrospective study conducted at Chiang-Mai University Hospital from 2012 to 2016. Patients 18 years of age and over and with a diagnosis of pENL were enrolled onto study. Data related to clinical presentations, histology, stage, treatment and response were collected. There were 104 pENL patients with a median age of 63 years included. The most common presentation was gastrointestinal symptoms (41%), followed by ear, nose, and throat symptoms (35%). Diffuse large B-cell lymphoma (DLBCL) was the most common morphological subtype (60%), followed by marginal zone lymphoma (15%). The majority of patients presented with stage II disease (55%). The five-year overall survival rate was 71%. The factors associated with mortality were hemoglobin <7 g/dL, B-symptoms and LDH above upper normal limits. This study illustrated that lymphoma can present at various extranodal sites. Gastrointestinal symptoms were the most common presentations and DLBCL was the most common subtype of pENL. Full article
2 pages, 359 KiB  
Case Report
Localized Lymphadenopathy with Myelodysplastic Syndrome Associated with Tuberculosis
by Aya Nakaya, Kazuyoshi Ishii, Toshiki Shimizu, Takeshi Tamaki, Yoshihisa Ishiura, Mayumi Inaba, Yoshiko Uemura, Hirokazu Nakamine and Shosaku Nomura
Hematol. Rep. 2019, 11(4), 8147; https://doi.org/10.4081/hr.2019.8147 - 29 Nov 2019
Cited by 1 | Viewed by 466
Abstract
We report the case of a man who developed myelodysplastic syndrome (MDS) and refractory cytopenia of unilineage dysplasia, 5 months after aortic valve replacement surgery. He also developed fever of unknown origin. After bone marrow- and other laboratory examinations, he was diagnosed with [...] Read more.
We report the case of a man who developed myelodysplastic syndrome (MDS) and refractory cytopenia of unilineage dysplasia, 5 months after aortic valve replacement surgery. He also developed fever of unknown origin. After bone marrow- and other laboratory examinations, he was diagnosed with tuberculosis. Full article
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-6
Previous Issue
Next Issue
Back to TopTop